Evaluation of risk factors for uric acid elevation in COVID-19 patients treated with favipiravir.
Hanai Y, Yoshizawa S, Matsuo K, Uekusa S, Miyazaki T, Nishimura K, Mabuchi T, Ohashi H, Ishii Y, Tateda K, Yoshio T, Nishizawa K.
Hanai Y, et al. Among authors: matsuo k.
Diagn Microbiol Infect Dis. 2022 Apr;102(4):115640. doi: 10.1016/j.diagmicrobio.2022.115640. Epub 2022 Jan 22.
Diagn Microbiol Infect Dis. 2022.
PMID: 35193798
Free PMC article.